Regulatory T cells in diabetes and gastritis

Autoimmunity Reviews

Volumn 8, Issue 8, 2009, Pages 659-662

  Alonso, Núria ^a,b   Soldevila, Berta ^a,b   Sanmartí, Anna ^a,b   Pujol Borrell, Ricardo ^a,b   Martínez Cáceres, Eva ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Autoimmune gastritis; Foxp3; Pepsinogen I; Regulatory T cells; T1D

Indexed keywords

AUTOANTIBODY; PARIETAL CELL ANTIBODY; PEPSINOGEN I;

DISEASE COURSE; DISEASE MARKER; GASTRITIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PERNICIOUS ANEMIA; PREVALENCE; REGULATORY T LYMPHOCYTE; REVIEW; SCREENING; STOMACH BIOPSY; STOMACH MUCOSA;

ANEMIA, PERNICIOUS; ANIMALS; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; GASTRITIS, ATROPHIC; HUMANS; PREVALENCE; T-LYMPHOCYTES, REGULATORY;

EID: 67349193568     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.02.014     Document Type: Review

References (40)

1. Kawasaki E., Gill R.G., and Eisenbarth G.S. Type 1 diabetes mellitus. In: Eisenbarth G.S. (Ed). Molecular mechanisms of endocrine and organ-specific autoimmunity (1999), R.G. Landes, Austin, Texas 149-182
2. Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group. Lancet 355 (2000) 873-876
3. Gale E.A. The rise of childhood type 1 diabetes in the 20th century. Diabetes 51 (2002) 3353-3361
4. Rainbow D.B., Esposito L., Howlett S.K., Hunter K.m., Todd J.A., Peterson L.B., et al. Commonality in the genetic control of Type 1 diabetes in humans and NOD mice: variants of genes in the IL-2 pathway are associated with autoimmune diabetes in both species. Biochem Soc Trans 36 (2008) 312-315
5. Daneman D. Type 1 diabetes. Lancet 11 367 (2006) 847-858
6. Knip M., and Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7 (2008) 550-557
7. De Block C.E., De Leeuw I.H., and Van Gaal L.F. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1(insulin-dependent) diabetic patients. The Belgian Diabetes Registry. J Clin Endocrinol Metab 84 (1999) 4062-4067
8. Barker J.M. Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab 91 (2006) 1210-1217
9. De Block C.E., De Leeuw I.H., and Van Gaal L.F. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J Clin Endocrinol Metab 93 (2008) 363-371
10. Huber A., Menconi F., Corathers S., Jacobson E.M., and Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 29 (2008) 697-725
11. Awata T., Kawasaki E., Tanaka S., Ikegami H., Maruyama T., Shimada A., et al. Association of type 1 diabetes with two loci on 12q13 and 16p13 and the influence of coexisting thyroid autoimmunity in Japanese. J Clin Endocrinol Metab 94 (2009) 231-235
12. Bao F., Yu L., Babu S., Wang T., Hoffenberg E.J., Rewers M., and Eisenbarth G.S. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 13 (1999) 143-148
13. Smyth D.J., Plagnol V., Walker N.M., Cooper J.D., Downes K., Yang J.H., Howson J.M., Stevens H., McManus R., Wijmenga C., Heap G.A., Dubois P.C., Clayton D.G., Hunt K.A., van Heel D.A., and Todd J.A. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 359 (2008) 2767-2777
14. De Block C.E., De Leeuw I.H., Rooman R.P., Winnock F., Du Caju M.V., and Van Gaal L.F. Gastric parietal cell antibodies are associated with glutamic aciddecarboxylase-65 antibodies and the HLA DQA1 * 0501DQB1 * 0301haplotype in type 1 diabetes mellitus. Belgian Diabetes Registry. Diabet Med 17 (2000) 618-622
15. Kupila A., Muona P., Simell T., Arvilommi P., Savolainen H., Hämäläinen A.M., Korhonen S., Kimpimäki T., Sjöroos M., Ilonen J., Knip M., and Simell O. Juvenile Diabetes Research Foundation Centre for the prevention of type i diabetes in Finland. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 44 (2001) 290-297
16. Barker J.M., Yu J., Yu L., Wang J., Miao D., Bao F., Hoffenberg E., Nelson J.C., Gottlieb P.A., Rewers M., and Eisenbarth G.S. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care 28 (2005) 850-855
17. Freemark M., and Levitsky L.L. Screening for celiac disease in children with type 1 diabetes: two views of the controversy. Diabetes Care 26 (2003) 1932-1939
18. Silverstein J., Klingensmith G., Copeland K., Plotnick L., Kaufman F., Laffel L., Deeb L., Grey M., Anderson B., Holzmeister L.A., and Clark N. American Diabetes Association. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28 1 (Jan 2005) 186-212
19. De Block C.E., De Leeuw I.H., Bogers J.J., Pelckmans P.A., Ieven M.M., Van Marck E.A., Van Acker K.L., and Van Gaal L.F. Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes Care 26 (2003) 82-88
20. Strickland R.G., and Mackay I.R. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 18 (1973) 426-440
21. Toh B.H., van Driel I.R., and Gleeson P.A. Pernicious anemia. N Engl J Med 337 (1997) 1441-1448
22. Irvine W.J., Cullen D.R., and Mawhinney H. Natural history of autoimmune achlorhydric atrophic gastritis. A 1-15-year follow-up study. Lancet 2 (1974) 482-485
23. Ungar B., Stocks A.E., Martin F.I., Whittingham S., and Mackay I.R. Intrinsic-factor antibody, parietal-cell antibody, and latent pernicious anaemia in diabetes mellitus. Lancet 2 (1968) 415-417
24. Storskrubb T., Aro P., Ronkainen J., Sipponen P., Nyhlin H., Talley N.J., et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol 43 (2008) 1448-1455
25. Alonso N., Granada M.L., Salinas I., Lucas A.M., Reverter J.L., Juncà J., Oriol A., and Sanmartí A. Serum pepsinogen I: an early marker of pernicious anemia in patients with type 1 diabetes. J Clin Endocrinol Metab 90 (2005) 5254-5258
26. Alonso N., Granada M.L., Salinas I., Reverter J.L., Flores L., Ojanguren I., Martínez-Cáceres E.M., and Sanmartí A. Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis. Eur J Endocrinol 157 (2007) 763-769
27. Chatenoud L., Salomon B., and Bluestone J.A. Suppressor T cells - they′re back and critical for regulation of autoimmunity. Immunol Rev 182 (2001) 149-163
28. Horwitz D.A., Zheng S.G., and Gray J.D. Natural and TGF-beta-induced Foxp3(+)CD4(+)CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol 29 (2008) 429-435
29. Lan R.Y., Ansari A.A., Lian Z.X., and Gershwin M.E. Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev 4 (2005) 351-363
30. Askenasy N., Kaminitz A., and Yarkoni S. Mechanisms of T regulatory cell function. Autoimmun Rev 7 (2008) 370-375
31. Lindley S., Dayan C.M., Bishop A., Roep B.O., Peakman M., and Tree T.I. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54 (2005) 92-99
32. Brusko T., Wasserfall C., McGrail K., Schatz R., Viener H.L., Schatz D., Haller M., Rockell J., Gottlieb P., Clare-Salzler M., and Atkinson M. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 56 (2007) 604-612
33. Brusko T.M., Wasserfall C.H., Clare-Salzler M.J., Schatz D.A., and Atkinson M.A. Functional defects and the influence of age on the frequency of CD4+CD25+ T-cells in type 1 diabetes. Diabetes 54 (2005) 1407-1414
34. Putnam A.L., Vendrame F., Dotta F., and Gottlieb P.A. CD4+CD25 high regulatory T cells in human autoimmune diabetes. J Autoimmun 24 (2005) 55-62
35. Weaver C.T., Hatton R.D., Mangan P.R., and Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25 (2007) 821-852
36. Schneider A., Rieck M., Sanda S., Pihoker C., Greenbaum C., and Buckner J.H. The effector T cells of diabetic subjects are resistant to regulation via CD4+FOXP3+ regulatory T cells. J Immunol 181 (2008) 7350-7355
37. Laurie K.L., van Driel I.R., and Gleeson P.A. The role of CD4+CD25+ immunoregulatory T cells in the induction of autoimmune gastritis. Immunol Cell Biol 80 (2002) 567-573
38. Van Driel I.R., Baxter A.G., Laurie K.L., Zwar T.D., La Gruta N.L., Judd L.M., et al. Immunopathogenesis, loss of T cell tolerance and genetics of autoimmune gastritis. Autoimmun Rev 1 (2002) 290-297
39. Cao D., Malmström V., Baecher-Allan C., Hafler D., Klareskog L., and Trollmo C. Isolation and functional characterization of regulatory CD25 bright CD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33 (2003) 215-223
40. Korn T., Reddy T., Gao N., Bettelli E., Awasthi A., Petersen T.R., et al. Myelin specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13 (2007) 423-431